Zimmer Partners’s LeonaBio Inc LONA Stock Holding History

Zimmer Partners’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,000	Closed	-$369K	–	125
2020 Q3	$369K	Buy	+2,000	New	+$334K	0.01%	113

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Zimmer Partners's LONA Position: Q4 2020 in Review

Zimmer Partners sold out of LeonaBio Inc (LONA) in Q4 2020, closing a stake of 2,000 shares — an estimated $369K sold.

Zimmer Partners first reported a position in LONA in Q3 2020 and held it in 1 quarter. The position peaked at $369K in Q3 2020. 70 funds tracked by Wall St. Rank hold LONA as of Q4 2020.

Zimmer Partners reported no remaining LeonaBio Inc position as of Q4 2020 after selling out during the quarter.
Zimmer Partners sold 2,000 LeonaBio Inc shares in Q4 2020, an estimated $369K.
Zimmer Partners first reported a position in LeonaBio Inc in Q3 2020 and held it in 1 quarter.
Zimmer Partners's LeonaBio Inc position peaked at $369K in Q3 2020.
70 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2020.

Based on Zimmer Partners's 13F filing for Q4 2020, filed 16 Feb 2021.